Frontiers in Oncology | Gastrointestinal Cancers: Colorectal Cancer

Original Research

Published on 10 Nov 2022

Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups

in Gastrointestinal Cancers: Colorectal Cancer

Peng Li
Qingyu Meng
Yonggan Xue
Zhipeng Teng
Hanlin Chen
Junli Zhang
Yang Xu
Sha Wang
Ruoying Yu
Qiuxiang Ou

Frontiers in Oncology

doi 10.3389/fonc.2022.1000146

6,003 views
4 citations

Original Research

Published on 10 Nov 2022

Active surveillance in long period of total neoadjuvant therapy in rectal cancer: Early prediction of poor regression response

in Gastrointestinal Cancers: Colorectal Cancer

Haoyu Zhang
Ke Cao
Ganbin Li
Zhiwei Zhai
Guanghui Wei
Hao Qu
Zhenjun Wang
Jiagang Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1049228

1,851 views
9 citations

Original Research

Published on 10 Nov 2022

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Adrien Grancher
Ludivine Beaussire
Sylvain Manfredi
Karine Le Malicot
Marie Dutherage
Vincent Verdier
Claire Mulot
Olivier Bouché
Jean-Marc Phelip
Charles-Briac Levaché

Frontiers in Oncology

doi 10.3389/fonc.2022.973167

2,788 views
8 citations

Methods

Published on 09 Nov 2022

Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies

in Gastrointestinal Cancers: Colorectal Cancer

Hiroshi Nakatsumi
Yoshito Komatsu
Tetsuhito Muranaka
Satoshi Yuki
Yasuyuki Kawamoto
Kazuaki Harada
Masayoshi Dazai
Miki Tateyama
Yusuke Sasaki
Takuto Miyagishima

Frontiers in Oncology

doi 10.3389/fonc.2022.939425

2,508 views
1 citation

Original Research

Published on 09 Nov 2022

Adjuvant chemoradiotherapy does not improve outcomes in patients with fistula-associated anal adenocarcinoma undergoing abdominoperineal resection

in Gastrointestinal Cancers: Colorectal Cancer

Min Wang
Yu Xiang
Yunshan Wang
Jiayi Zhang
Haoran Zhao
Can Wang
Lichao Qiao
Bolin Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1061513

1,217 views
2 citations

Original Research

Published on 07 Nov 2022

The prognostic impact of BMI on colorectal cancer is stratified by tumor location

in Gastrointestinal Cancers: Colorectal Cancer

Zixi Zhang
Xueli Yan
Yan Lu
Xiaowen Guo
Min Jiao
Weizhong Wang
Boqian Sun
Yi Zhou
Qinglin Hu
Dake Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.987518

1,889 views
1 citation

Original Research

Published on 07 Nov 2022

Nomogram for prediction of peritoneal metastasis risk in colorectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Xian-qing Song
Zhi-xian Liu
Qing-yuan Kong
Zhen-hua He
Sen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.928894

2,875 views
4 citations

Original Research

Published on 03 Nov 2022

Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Fei Xie
Qin Zhao
Shuqi Li
Shuangshuang Wu
Jinli Li
Haojiang Li
Shenghuan Chen
Wu Jiang
Annan Dong
Liqing Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.901287

2,031 views
3 citations

Systematic Review

Published on 03 Nov 2022

Frailty affects prognosis in patients with colorectal cancer: A systematic review and meta-analysis

in Gastrointestinal Cancers: Colorectal Cancer

Minghao Cai
Zhongyan Gao
Junyi Liao
Yuanping Jiang
Yong He

Frontiers in Oncology

doi 10.3389/fonc.2022.1017183

4,027 views
20 citations

Original Research

Published on 02 Nov 2022

Development and validation of a prognostic model to predict the prognosis of patients with colorectal gastrointestinal stromal tumor: A large international population-based cohort study

in Gastrointestinal Cancers: Colorectal Cancer

Yiding Li
Yujie Zhang
Yang Fu
Wanli Yang
Xiaoqian Wang
Lili Duan
Liaoran Niu
Junfeng Chen
Wei Zhou
Jinqiang Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1004662

2,264 views
4 citations

Opinion

Published on 02 Nov 2022

Crosstalk between enteric serotonergic neurons and colorectal cancer stem cells to initiate colorectal tumorigenesis

in Gastrointestinal Cancers: Colorectal Cancer

Jiamei Jia
Mengmeng Wang
Shuqiao Xing
Zhihui Huang
Yuanyuan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1054590

1,905 views
6 citations

Original Research

Published on 01 Nov 2022

The difference of human gut microbiome in colorectal cancer with and without metastases

in Gastrointestinal Cancers: Colorectal Cancer

Leitao Sun
Zhenzheng Zhu
Xinru Jia
Xiangchang Ying
Binbin Wang
Peipei Wang
Shuo Zhang
Jieru Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.982744

4,371 views
7 citations

Review

Published on 01 Nov 2022

A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Yuansen Li
Yi Lei
Jiaxue Sun
Wanfu Zhang
Xiaogang Li
Sijing Chen
Deshenyue Kong
Cheng Chen
Ke Bi
Xiao Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1020400

3,577 views
5 citations

Review

Published on 31 Oct 2022

The progress of protein synthesis factors eIFs, eEFs and eRFs in inflammatory bowel disease and colorectal cancer pathogenesis

in Gastrointestinal Cancers: Colorectal Cancer

Conggai Huang
Qi Zhao
Xiaoqing Zhou
Ran Huang
Yi Duan
Johannes Haybaeck
Zhihui Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.898966

3,415 views

Original Research

Published on 28 Oct 2022

An analysis of sexual dimorphism in the tumor microenvironment of colorectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Andrea E. Geddes
Anita L. Ray
Robert A. Nofchissey
Azadeh Esmaeili
Apryl Saunders
Dawn E. Bender
Maaz Khan
Sheeja Aravindan
Jared T. Ahrendsen
Min Li

Frontiers in Oncology

doi 10.3389/fonc.2022.986103

2,426 views
6 citations

Original Research

Published on 27 Oct 2022

Platycodin D sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the PI3K/Akt signaling pathway

in Gastrointestinal Cancers: Colorectal Cancer

Yanfei Liu
Shifeng Tian
Ben Yi
Zhiqiang Feng
Tianhao Chu
Jun Liu
Chunze Zhang
Shiwu Zhang
Yijia Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1046143

3,299 views
12 citations